Back to DAVENPORT & Co LLC DAVENPORT & Co LLC

LTRNLTRN
Showing 8 of 9 quarters

Position history for DAVENPORT & Co LLCDAVENPORT & Co LLC's holdings in LANTERN PHARMA INC

DAVENPORT & Co LLC holds 23,814 shares of LTRN (LANTERN PHARMA INC), worth $99,304 as of 2026-Q2. LTRN represents 0.0% of DAVENPORT & Co LLC's portfolio.

Current Value

$99,304

Current Shares

23,814

Total Value Change

-$98,193

Total Shares Change

-30,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
23,814
0.0%
$99,3040.0%$4.17
0
2026-Q1
Unchanged
23,814
0.0%
$32,6250.0%$2.71
0
2025-Q4
Decreased
23,814
-7.8%
$72,1560.0%$3.06
0
2025-Q3
Unchanged
25,814
0.0%
$112,2910.0%$4.54
0
2025-Q2
Unchanged
25,814
0.0%
$81,5720.0%$3.19
0
2025-Q1
Unchanged
25,814
0.0%
$91,3820.0%$3.55
0
2024-Q4
Decreased
25,814
-52.0%
$82,3470.0%$3.27
0
2024-Q3
Decreased
53,814
-15.7%
$197,4970.0%$3.78
0

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used